Background Published cases of iatrogenic cerebral amyloid angiopathy (iCAA) are increasing; however, their geographic ...
Background Psychiatric comorbidities are increasingly recognised in demyelinating diseases, yet their frequency and timing in ...
Background The role of physical activity in the risk of amyotrophic lateral sclerosis (ALS) is debated. It is also unclear whether the association differs in people at high genetic risk of ALS.
Background Status epilepticus (SE) is associated with substantial mortality and morbidity that increase with seizure duration. Prompt diagnosis is essential, but access to electroencephalography (EEG) ...
Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with the global epidemiological profile remaining incompletely understood. While previous systematic reviews existed ...
Background Anti-amyloid therapies for Alzheimer’s disease (AD) require efficient patient selection. The Clinical Dementia Rating (CDR) scale is the reference standard for staging, but it is ...
In JNNP, Konen et al provide real-world evidence that, in carefully selected stable patients with multiple sclerosis (MS), discontinuation of ocrelizumab after about 30 months was not associated with ...
Original research: Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study (20 May, 2026) ...
is a leading international journal publishing the latest research and reviews on all areas of neurological sciences.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Background The pathogenic mechanisms underlying autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A), a central nervous system disorder associated with GFAP autoimmunity, remain ...
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare Central Nervous System (CNS) inflammatory disorder, first defined in 2016 and identified by GFAP-IgG in cerebrospinal fluid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results